Companies: 10,795·Total market cap: $144.5T
P3 Health Partners Inc.

P3 Health Partners Inc.

PIIINASDAQHealthcare● Active
$12.03
+$0.45(+3.89%)
Market Cap$39627855
P/E Ratio
52W High$16.89
52W Low$1.52

P3 Health Partners Inc. (PIII) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

piii · stock forecast · 4 analysts (3M) · FMP · updated Jun 8, 2026

Analyst Rating & Consensus

Based on 4 Wall Street analysts in the past 3 months

SellBuy

Buy

4 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
2
Hold
2
Sell
0
Strong Sell
0
Total: 4 · Buy rate: 50.0%

12-Month Price Target

High

$14.00

Consensus

$9.00

-26.5% upside

Low

$4.00

Median: $9 · Last Close: $12.25

The P3 Health Partners Inc. (PIII) analyst consensus is Buy, based on ratings from 4 Wall Street analysts over the past 3 months. The average 12-month PIII price target is $9.00, representing -26.5% upside from the current price of $12.25.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $9 (-26.5%)

Consensus Target

$9.00

-26.5% upside

High Target

$14

14.3%

Low Target

$4

-67.3%

Current Price

$12.25

as of today

Based on analyst price targets, the PIII stock price prediction for the next 12 months ranges from $4 to $14. The consensus PIII price forecast of $9.00 implies -26.5% upside from the current price of $12.25.

Short-Term Price Prediction

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-09$12.250.00%

1-day model range: $11.96–$12.54. Peak: $12.54 (+0.00%).

Long-Term Stock Price Prediction

⚠️ Long-term projections are hidden until 252 trading days of history (IPO / limited listing). Short-term tab may still show model output.

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

NEUTRAL

Based on 14 technical indicators

14%72%14%
2Buy
10Neutral
2Sell
RSI (14)50.0Neutral
MACDNEUTRAL

Refreshes daily from EOD close

Moving Averages · PIII · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$11.54BUY
MA 10$12.82SELL
MA 20$0.00NEUTRAL
MA 50$0.00NEUTRAL
MA 100$0.00NEUTRAL
MA 200$0.00NEUTRAL
Current $PIII · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$11.90BUY
EMA 10$12.75SELL
EMA 20$0.00NEUTRAL
EMA 50$0.00NEUTRAL
EMA 100$0.00NEUTRAL
EMA 200$0.00NEUTRAL
Current $PIII · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
TD Cowen2026-05-22
Maintains
HoldHold
Lake Street2026-05-15
Maintains
BuyBuy
TD Cowen2026-04-02
Maintains
HoldHold
Lake Street2026-03-27
Maintains
BuyBuy
Lake Street2025-11-17
Maintains
BuyBuy
Lake Street2025-04-21
Maintains
BuyBuy
TD Cowen2024-11-20
Maintains
HoldHold
BTIG2024-04-01
Downgrade ↓
BuyNeutral
Lake Street2024-03-14
Maintains
BuyBuy
William Blair2022-01-04
Maintains
OutperformOutperform

Wall Street analysts have recently issued updated ratings on P3 Health Partners Inc. (PIII) stock. Of the recent 10 rating actions, 0 were upgrades and 1 were downgrades. 4 analysts currently cover PIII.

Analyst Recommendation Trends

Buy ratings01↑ +1
Hold ratings11
Sell ratings00

PIII analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 1 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$1.4B

↓ 1.8% YoY

Revenue Next Year

$1.5B

↑ 7.5% YoY

EPS This Year

$-0.57

EPS Next Year

$-28.01

↑ 4796.1% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast PIII EPS of $-0.57 for the current fiscal year, based on estimates from 1 analysts. The PIII revenue forecast is $1.4B for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The PIII stock forecast is supported by two independent data sources: analyst consensus ratings from 4 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus PIII price target is $9.00 (-26.5% upside), with an analyst consensus of Buy.

The PIII short-term stock prediction for tomorrow is $12.25 (+0.00%).

P3 Health Partners Inc. trades on NASDAQ under the ticker PIII. The PIII stock outlook for 2027 is broadly positive, supported by a Buy consensus among 50% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

PIII forecast · 8 questions

According to 4 Wall Street analysts, the average 12-month PIII price target is $9.00, with a high forecast of $14.00 and a low of $4.00. The median price target is shown in the chart above when available. This implies -26.5% potential upside from the current price of $12.25.

PIII price targetWhat is PIII price targetPIII analyst price targetPIII 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.